About Stratec SE (SBS)
Stratec SE is a Medical Devices company operating in the Healthcare sector. The company is headquartered in Birkenfeld, Germany. SBS has been publicly traded since 2000, giving it 26+ years of trading history.
Stratec SE (SBS) has been publicly traded since 2000, making it a 26-year-old public company. It operates in the Medical Devices industry within the Healthcare sector. The company is headquartered in Birkenfeld, Germany and employs approximately 1,420 people. With a market capitalization of €229 million, SBS is a micro-cap company.
SBS trades on the German stock exchanges (XETRA/Frankfurt) and is classified as a micro-cap-cap stock with a market capitalization of approximately €229 million. The company employs approximately 1,420 people worldwide.
Key Statistics
- Current Price
- €18.84
- Market Cap
- €229.02M
- 52-Week High
- €33.10
- 52-Week Low
- €18.30
- Sector
- Healthcare
- Industry
- Medical Devices
SBS Investment Performance
SBS has declined 16.1% year-to-date in 2026. Over the past 5 years, a €1,000 investment in SBS would have grown to €175, representing a -82.5% total return. Since its IPO in 2000, a €1,000 investment would now be worth €3,607.
€1,000 Invested in Stratec SE (SBS)
How much would €1,000 invested in SBS be worth today?
What would €1,000 invested in SBS 1 year ago be worth today?
A €1,000 investment in Stratec SE (SBS) in 2025 would be worth €791 as of March 2026, representing a -20.9% total return.
What would €1,000 invested in SBS 3 years ago be worth today?
A €1,000 investment in Stratec SE (SBS) in 2023 would be worth €317 as of March 2026, representing a -68.3% total return.
What would €1,000 invested in SBS 5 years ago be worth today?
A €1,000 investment in Stratec SE (SBS) in 2021 would be worth €175 as of March 2026, representing a -82.5% total return.
What would €1,000 invested in SBS 10 years ago be worth today?
A €1,000 investment in Stratec SE (SBS) in 2016 would be worth €504 as of March 2026, representing a -49.6% total return.
What would €1,000 invested in SBS at IPO be worth today?
A €1,000 investment in Stratec SE (SBS) at IPO would be worth €3,607 as of March 2026, representing a +260.7% total return.
Monthly Returns Heatmap
Over the past 25+ years (309 months), Stratec SE (SBS) has averaged a monthly return of +1.72% with a median return of +0.79%. The stock had 162 positive months (52%) and 138 negative months (45%). The best month in SBS's history was October 2000 with a +170.0% return, while the worst was December 2000 at -83.3%. Historically, April tends to be the strongest month (averaging +7.1%), and March the weakest (-3.4%).
SBS's longest winning streak was 8 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2005 with a cumulative return of +108.9%, and the worst was 2023 at -48.5%.
Annual Returns
Over 26 years of trading history, Stratec SE (SBS) has delivered an average annual return of +21.55% with a median return of +7.11%. The compound annual growth rate (CAGR) is +9.27%. The stock posted gains in 14 years (54%) and losses in 12 years (46%).
SBS's best year was 2005 with a +165.09% gain, while the worst was 2002 at -51.81%. The longest streak of consecutive positive years was 4, and the longest losing streak was 5 years. SBS achieved double-digit gains (10%+) in 13 years. It suffered double-digit losses in 10 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -16.08% | €22.45 | €18.84 |
| 2025 | -22.94% | €29.13 | €22.45 |
| 2024 | -33.74% | €43.97 | €29.13 |
| 2023 | -42.96% | €77.07 | €43.97 |
| 2022 | -40.59% | €129.73 | €77.07 |
| 2021 | +13.09% | €114.71 | €129.73 |
| 2020 | +103.46% | €56.38 | €114.71 |
| 2019 | +22.90% | €45.88 | €56.38 |
| 2018 | -21.52% | €58.45 | €45.88 |
| 2017 | +43.41% | €40.76 | €58.45 |
| 2016 | -23.82% | €53.51 | €40.76 |
| 2015 | +35.30% | €39.55 | €53.51 |
| 2014 | +53.73% | €25.72 | €39.55 |
| 2013 | -18.47% | €31.55 | €25.72 |
| 2012 | +20.70% | €26.14 | €31.55 |
| 2011 | +1.13% | €25.85 | €26.14 |
| 2010 | +22.01% | €21.19 | €25.85 |
| 2009 | +100.04% | €10.59 | €21.19 |
| 2008 | -33.90% | €16.02 | €10.59 |
| 2007 | -5.12% | €16.89 | €16.02 |
| 2006 | +48.33% | €11.38 | €16.89 |
| 2005 | +165.09% | €4.29 | €11.38 |
| 2004 | +102.94% | €2.12 | €4.29 |
| 2003 | +143.23% | €0.87 | €2.12 |
| 2002 | -51.81% | €1.81 | €0.87 |
| 2001 | -4.00% | €1.88 | €1.81 |
SBS Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Stratec SE as an investment
Valuation
SBS currently trades at a trailing P/E ratio of 14.8, which is considered low relative to the broader market. The forward P/E of 11.3 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 1.0. The price-to-sales ratio is 0.9.
Dividends
Stratec SE pays a dividend to shareholders with a current yield of 3.18%. This translates to €0.60 per share annually. The payout ratio of 47% indicates sustainable dividend coverage.
Risk & Volatility
SBS has a beta of 0.72, indicating it is less volatile than the overall market. The stock's 52-week range is €18.30 to €33.10, and it currently trades near its 52-week low.
Analyst Ratings
Based on 5 analyst opinions, SBS has a consensus "strong_buy" rating. The average price target of €29.62 suggests 57.2% upside from current levels.
Frequently Asked Questions: SBS
What sector is SBS in? ▼
SBS operates in the Healthcare sector, specifically in the Medical Devices industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has SBS performed historically? ▼
Over 26 years of trading history, SBS has posted gains in 14 years (54% of the time). The best year was 2005 with a +165.1% return. Past performance does not guarantee future results.
How can I invest in SBS? ▼
You can invest in SBS through any brokerage account that offers access to German exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold SBS.
Does SBS pay dividends? ▼
Stratec SE pays a dividend to shareholders with a current yield of 3.18%. This translates to €0.60 per share annually. The payout ratio of 47% indicates sustainable dividend coverage.
What does Stratec SE do? ▼
Stratec SE is a Medical Devices company operating in the Healthcare sector. The company is headquartered in Birkenfeld, Germany.
What sector is SBS in? ▼
SBS operates in the Healthcare sector, specifically in the Medical Devices industry.
When did SBS go public? ▼
Stratec SE went public in 2000, making it a 26-year-old public company as of 2026.
How much would €1,000 invested in SBS 5 years ago be worth today? ▼
A €1,000 investment in SBS five years ago would be worth approximately €175 today, representing a -82.5% return.
How much would €1,000 invested in SBS 10 years ago be worth today? ▼
A €1,000 investment in SBS ten years ago would be worth approximately €504 today, representing a -49.6% total return over the decade.
What is SBS's 3-year return? ▼
Over the past 3 years, SBS has returned -68.3%. A €1,000 investment would have grown to €317.
How much would €1,000 invested in SBS at IPO be worth today? ▼
If you invested €1,000 in SBS at its IPO in 2000, it would be worth approximately €3,607 today, a 260.7% return over 26 years.
Does SBS pay dividends? ▼
Yes, Stratec SE pays a dividend with a current yield of 3.18%, which is €0.6 per share annually.
What is SBS's market cap? ▼
Stratec SE has a market capitalization of €229 million, classifying it as a micro-cap company.
What is SBS's P/E ratio? ▼
SBS has a trailing P/E ratio of 14.8 and a forward P/E of 11.3, which measures how much investors are paying per dollar of earnings.
Is SBS a buy, hold, or sell? ▼
Based on 5 opinions, SBS has a consensus "strong_buy" rating. The average price target is €29.62.
Last updated: 3/15/2026